Related Articles

• Therapeutic drug monitoring and tyrosine kinase inhibitors (Review)
• Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)
• Tyrosine kinase inhibitors in breast cancer (Review)
• Molecular mechanisms of lung‑specific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors (Review)
• Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non‑small‑cell lung cancer (Review)